Deciphering a contribution by Parkinson's susceptibility gene LRRK2 to lung cancer immunosuppression

破译帕金森氏症易感基因 LRRK2 对肺癌免疫抑制的贡献

• 批准号: 407427
• 负责人: Gorski Sharon M
• 金额: $ 4.37万
• 依托单位: BC Cancer, part of PHSA (Vancouver)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-02-01 至 2021-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=407427&lang=en
• 关键词: Environment Cancer

Lung cancer is the leading cause of death from cancer for both men and women in Canada. We need better strategies for lung cancer detection, treatment, and for identifying patients most likely to respond to emerging therapies. We discovered that an import

在加拿大，肺癌是男性和女性死于癌症的首要原因。我们需要更好的策略来检测、治疗肺癌，并识别最有可能对新兴疗法有反应的患者。我们发现一种进口